Philips expands technology leadership in image-guided therapy with acquisition of CardioProlific Inc.

Press Release | June 29, 2017 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial details of the transaction will not be disclosed. […]

BiO2 Medical Release: Angel Catheter Pivotal Study Published In Journal Of Vascular And Interventional Radiology

GOLDEN, Colo., June 29, 2017 /PRNewswire/ — Bio2 Medical today announced the results of the Angel® Catheter pivotal study, “Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients,” published in the Journal of Vascular and Interventional Radiology (JVIR).  The […]

Royal Philips Electronics N.V. (PHG) Slams Down $2.16 Billion for Spectranetics (SPNC)

6/28/2017 5:53:44 AM  Philips To Acquire The Spectranetics Corporation To Accelerate Expansion In Image-Guided Therapy Devices To Treat Cardiac And Peripheral Vascular Disease  AMSTERDAM, the Netherlands and COLORADO SPRINGS, Colo., June 28, 2017 (GLOBE NEWSWIRE) — Royal Philips(NYSE:PHG) (AEX:PHIA), a global leader in health technology, and The Spectranetics Corporation (NASDAQ:SPNC), a U.S.-based global […]

Heart Endovascular & Rhythm of Texas Begins First Commercial, FDA-Cleared, In-Patient Use of DABRA™ to Treat Peripheral Artery Disease

SAN ANTONIO–(BUSINESS WIRE)–Today, the Heart Endovascular & Rhythm of Texas announced its latest collaboration with Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, to use its groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease (PAD) in order to combat the growing rise of diabetic […]

Shockwave Medical Announces U.S. Commercial Availability Of Lithoplasty System And Enrollment Of First Patient In DISRUPT PAD III Global Clinical T

FREMONT, Calif.–(BUSINESS WIRE)–Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced two milestones for its Lithoplasty® System for the treatment of calcified plaque in patients with peripheral artery disease (PAD): enrollment of the first patient in the global DISRUPT PAD III clinical trial at the Medical […]

TVA Medical Release: Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology

AUSTIN, Texas, June 15, 2017/PRNewswire/ — TVA Medical, Inc. today announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQTM endoAVF System. The 12-month data published online in the American Journal of Kidney Diseases (AJKD), the official journal of the National Kidney Foundation, […]

Distinguished Vascular Surgeon, Douglas Paget, MD, FACS, RVT will be Spotlighted in The Leading Physicians of the World

PR NewsChannel: The International Association of HealthCare Professionals is pleased to welcome Douglas Paget, MD, FACS, RVT, Vascular Surgeon to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Paget is a highly trained and qualified surgeon with an extensive expertise in all facets […]

Europe’s LimFlow Hires a COO and Opens Bay Area Office

LimFlow Expands Senior Management Team And Opens Silicon Valley Office PARIS–(BUSINESS WIRE)–LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), today announced the expansion of the company’s senior management team. Sophie Humbert, PhD, has been appointed […]

Cagent Vascular Completes Enrollment of PRELUDE Study Using Serranator Device

WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular disease interventions, including the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon Catheter, announces the completion of enrollment in the First-in-Human PRELUDE Study. The purpose of this prospective, single-arm, multicenter feasibility study is to show […]